Skanjeti A - Search Results

1

18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.

Dubreuil J, Giammarile F, Rousset P, Rubello D, Colletti PM, Glehen O, Skanjeti A. Dubreuil J, et al. Among authors: skanjeti a. Nucl Med Commun. 2017 Jan;38(1):1-9. doi: 10.1097/MNM.0000000000000613. Nucl Med Commun. 2017. PMID: 27820721 Review.

2

FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.

Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, Bisi G. Pelosi E, et al. Among authors: skanjeti a. Q J Nucl Med Mol Imaging. 2008 Mar;52(1):9-16. Q J Nucl Med Mol Imaging. 2008. PMID: 18235420 Free article.

3

PET in the clinical work-up of patients with spondylodiscitis: a new tool for the clinician?

Skanjeti A, Penna D, Douroukas A, Cistaro A, Arena V, Leo G, Longo G, Traverso A, Belloro S, Pelosi E. Skanjeti A, et al. Q J Nucl Med Mol Imaging. 2012 Dec;56(6):569-76. Q J Nucl Med Mol Imaging. 2012. PMID: 23358410

4

18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis.

Stelzmueller I, Huber H, Wunn R, Hodolic M, Mandl M, Lamprecht B, Schinko H, Fellner F, Skanjeti A, Giammarile F, Colletti PM, Rubello D, Gabriel M. Stelzmueller I, et al. Among authors: skanjeti a. Clin Nucl Med. 2016 Apr;41(4):e187-94. doi: 10.1097/RLU.0000000000001102. Clin Nucl Med. 2016. PMID: 26704732

5

FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma.

Dubreuil J, Moreau A, Sarkozy C, Traverse-Glehen A, Skanjeti A, Salles G, Giammarile F. Dubreuil J, et al. Among authors: skanjeti a. Clin Nucl Med. 2016 May;41(5):397-8. doi: 10.1097/RLU.0000000000001111. Clin Nucl Med. 2016. PMID: 26825213

6

FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.

Dubreuil J, Giammarile F, Rousset P, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A. Dubreuil J, et al. Among authors: skanjeti a. Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1630-7. doi: 10.1007/s00259-016-3347-z. Epub 2016 Feb 24. Eur J Nucl Med Mol Imaging. 2016. PMID: 26907364 Clinical Trial.

7

Erratum to: FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.

Dubreuil J, Giammarile F, Rousset P, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A. Dubreuil J, et al. Among authors: skanjeti a. Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1570. doi: 10.1007/s00259-016-3387-4. Eur J Nucl Med Mol Imaging. 2016. PMID: 27044382 No abstract available.

8

Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Cacicedo J, Navarro A, Del Hoyo O, Gomez-Iturriaga A, Alongi F, Medina JA, Elicin O, Skanjeti A, Giammarile F, Bilbao P, Casquero F, de Bari B, Dal Pra A. Cacicedo J, et al. Among authors: skanjeti a. Br J Radiol. 2016 Nov;89(1067):20160217. doi: 10.1259/bjr.20160217. Epub 2016 Aug 2. Br J Radiol. 2016. PMID: 27416996 Free PMC article. Review.

9

Diffusion-weighted MRI and 18F-FDG-PET/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature.

Dubreuil J, Tordo J, Rubello D, Giammarile F, Skanjeti A. Dubreuil J, et al. Among authors: skanjeti a. Nucl Med Commun. 2017 Jan;38(1):84-90. doi: 10.1097/MNM.0000000000000612. Nucl Med Commun. 2017. PMID: 27898647 Review.

10

Diffuse Subcutaneous Fat Involvement in a Marginal Zone Lymphoma.

Dubreuil J, Noel R, Tordo J, Salles G, Skanjeti A. Dubreuil J, et al. Among authors: skanjeti a. Clin Nucl Med. 2017 Feb;42(2):129-130. doi: 10.1097/RLU.0000000000001467. Clin Nucl Med. 2017. PMID: 27941375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page